Credits: Canva
Can you leave your most valued dream—having a baby—into the hands of your fertility clinic? After enduring the emotional, physical, and financial rollercoaster of IVF—only to find out the baby you've carried isn't biologically yours. That's what happened to a woman in Brisbane, Australia, in a case that's now making headlines globally. A Brisbane IVF mix-up has left the world reeling after a woman gave birth to another couple's baby without realizing it, due to a tragic embryo transfer mistake. As this cinematic-style medical disaster unfolds, discussions about embryo safety, fertility ethics, and responsibility are taking center stage.
The incident took place at one of Australia's largest fertility clinics, where a human mistake involved the implantation of a stranger's embryo into another woman by mistake. What happened did not only traumatize the involved families but has raised immediate questions about regulation, ethics, and patient safeguards in the multi-billion-dollar IVF industry.
The error was discovered in February 2025, when the child's biological parents—hereafter called the birth parents—asked for the transfer of their remaining frozen embryos to another fertility clinic. But Monash IVF employees had a shocking discovery: the count of embryos stored was not as recorded. One extra embryo was discovered, giving rise to a chilling finding—one of their embryos had already been implanted in another patient.
Later investigations confirmed that an embryo from this couple had been accidentally thawed and implanted in another woman, who gave birth to a genetically unrelated child.
Monash IVF's CEO Michael Knaap apologized publicly for the incident, referring to it as a moment of profound regret for the organization.
"On behalf of Monash IVF, I would like to express how deeply sorry I am for what has transpired," Knaap stated. "We are distraught, and we apologize to all concerned."
The clinic notified the regulatory bodies, such as the Reproductive Technology Accreditation Committee and Queensland's assisted reproductive technology regulator, and initiated an internal investigation. Knaap reassured the public that extra audits were under way and recalled senior counsel Fiona McLeod to independently examine the breach, committing to adopt all of her findings in full.
Though, this is not the first such scandal Monash IVF has encountered. Earlier this year in 2023, the clinic had agreed on a A$56 million (approx. $36 million USD) class-action lawsuit settlement over claims that up to 700 patients' embryos had been mistakenly destroyed as their genetic screening results had identified these healthy embryos as abnormal.
This case highlights the susceptibility of patients who undergo in vitro fertilization (IVF)—a sophisticated medical procedure where eggs are extracted from a woman's ovaries, fertilized in a laboratory, and inserted into the uterus after they have grown into embryos.
Although IVF brings promise to millions of couples with fertility problems, it's also an emotionally, physically, and financially exhausting process. A single IVF cycle in the U.S. and Australia averages up to $15,000, and success is never assured. Nearly 20,690 babies were born through IVF in Australia and New Zealand in 2021 alone, says the University of New South Wales.
But for all its life-giving possibilities, IVF is impressively procedural, and any leak in protocol—particularly when thawing or transferring embryos—can be irreversible.
What is the situation when a woman gives birth to another's child? What are the rights of the biological and gestational parents? These are no longer hypothetical questions—they are now at the center of an existing legal and ethical tempest.
Up to now, Monash IVF has not admitted any liability, although it paid former patients in past accidents. The company maintains this recent mistake was an isolated incident, but critics and lobby groups contend the latest episode indicates systematic failures of quality control and highlights larger issues around transparency within the fertility industry.
The families' identity is protected for legal and psychological reasons, but analysts forecast custody arrangements, emotional trauma, and possible litigation may be the overriding themes in the aftermath for months—if not years—to come.
For a process as precise and delicate as IVF, the value of fail-safe tracking mechanisms, double-checking procedures, and independent reviews cannot be overemphasized. Watchdogs in the U.S., U.K., and other countries are keeping a close eye on the verdict of this case, looking at it as an international warning tale.
In the United States, where IVF is privately funded and unregulated at the federal level, this case may further fuel calls for national oversight boards, improved data transparency, and universal best-practice protocols.
In the meantime, pressure is mounting on advocacy groups to provide psychological counseling for the gestational mother and the biological parents of this traumatic situation. IVF has enabled parenthood for millions. But as technology improves and demand increases, the systems developed to support reproductive health need to improve with similar rigor.
Embryo mix-ups can be emotionally traumatic for all parties involved. Immediate psychological support is crucial to help individuals process shock, grief, and confusion. Offering access to licensed therapists specializing in fertility trauma can create a safe space for emotional expression. Clinics must provide ongoing counseling, not just post-incident, but throughout the legal and ethical aftermath.
Support groups with like individuals can also promote community and empathy. Open communication, compassionate healthcare providers, and trauma-informed care work to restore trust and emotional stability during this very intimate crisis. Prioritizing mental health is crucial for healing.
Credit: iStock
Singapore is seeing a significant rise in COVID-19 cases, driven by the NB.1.8.1 variant from the Omicron family, nicknamed “Nimbus”.
According to a statement from the Communicable Diseases Agency, the number of COVID cases in Singapore rose to 12,700 in the week of May 10 to May 16, compared with 8,000 in the previous week.
The country is also seeing a rise in the number of daily COVID hospitalizations — from 56 to 73 during the same period, with one case in the intensive care unit daily on average, the CDA said.
The NB.1.8.1 variant is currently the dominant strain circulating in Singapore and accounts for more than half of locally sequenced cases.
The CDA noted that people at extremes of age, such as those aged 60 years and above, including those staying in aged care facilities, and medically vulnerable people aged six months and above, are at increased risk of severe COVID infection and should stay updated with vaccinations.
Calling the increase a “periodic wave” of COVID that “is expected throughout the year”, the agency said it is monitoring the spike.

“There is no indication that the variants circulating locally are more transmissible or cause more severe disease compared with previously circulating variants,” it added.
The CDA noted that the surge in cases may be due to waning population immunity, and stated that the currently available vaccine in the country continues to be effective for protection against this variant..
Also read: Child Mortality Rates In US Saw A Massive 6.6% Rise In Just 3 Years, Study Finds
NB.1.8.1 was first detected in January 2025. It is a “recombinant” variant, meaning it formed when two or more older variants mixed their genetic material.
On May 23, 2025, the World Health Organization (WHO) classified NB.1.8.1 as a “Variant Under Monitoring” (VUM). Scientists have identified changes in the virus that could affect how it spreads or infects people, although evidence is still evolving.
Previous laboratory studies also suggest the variant binds more tightly to human cells, indicating it may infect people more effectively than earlier variants.
People infected with NB.1.8.1 commonly report:
Some patients also experience:
One unusual symptom linked to the variant is a severe “razor blade” sore throat, where people report sharp pain while swallowing food or beverages.
Read More: Europe Sees Record Surge In Gonorrhea, Syphilis Cases In Over A Decade: ECDC
Vaccination remains the best protection against severe illness, especially for:
Other Safety Measures
Authorities advised the public to continue basic preventive practices such as:
Cleaning or household chores can give you a sense of accomplishment when completed. (Photo credit: iStock)
During the hot days of the year, amid a severe heatwave, it is only natural to feel irritable and anxious. But according to psychologists, some simple household chores will not just give you a sense of calm but will also work like meditation. Experts have found that manual chores like clearing away clutter, sweeping, and mopping prevent the mind from wandering while giving a concrete sense of accomplishment. Psychologists say that the process of cleaning is meditative and calming.
Experts and Zen monks often say that before enlightenment, one must carry water and chop wood. And even after enlightenment, the same process must be repeated. Repetitive activities like these can regulate the nervous system, as these acts are structured, predictable, and give a sense of completion at the end.
Zen monks and psychologists recommend mopping the floor, as this activity gives a sense of grounding and control. Additionally, one can immediately see the results of one's work, which is more satisfying than cognitive and emotional tasks that have slow results. "Unsui" monks spend most of their time tidying and cleaning. In A Monk's Guide to a Clean House and Mind, a monk wrote that they sweep dust to remove worldly desires and scrub dirt to free themselves from attachment. This time spent cleaning everything carefully, they say, is extremely fulfilling.
Psychologists say that people who dread cleaning or find it daunting can engage in the activity to improve focus rather than stress about a to-do list. People who see cleaning as drudgery often feel that the shift is less about forcing oneself to enjoy it than about changing the way one engages with the activity. But the key here is not to rush through the process — experts say that it is imperative to pay attention to the rhythm of the physical movement or to things like water temperature.
When slowed down, it helps one focus on the sensory aspects, and it can start to function like a mindfulness exercise. Cleaning is an opportunity to free the mind and care for oneself and the world. For monks, cleaning is not just about fixing a room; it is a way to expand oneself and nurture one's relationship with the world. Therefore, instead of looking for a perfect result, it is important to embrace incompletion without anxiety.
When one feels overwhelmed, it is not about the task but about what the task represents. This could be self-judgement, time pressure, or anxiety, for instance. Breaking a task down into small and defined actions can reduce barriers. Therefore, instead of getting engrossed in the activity, one must try to break the task down into smaller and defined actions that reduce barriers. Start by choosing one room or surface to clean. Start with baby steps and then ease into the process. This awareness will give you a sense of peace similar to what one finds in temples.
Credit: iStock
The Union Ministry of Health and Family Welfare today notified the inclusion of the drug “Pregabalin” under Schedule H1 of the Drugs Rules, 1945, to strictly regulate the painkiller amid rising concerns over its misuse and abuse, particularly among youth.
Pregabalin, sold under the brand names Axalid and Lyrica, is a prescription medication used to treat epilepsy, neuropathic (nerve) pain, fibromyalgia, and generalized anxiety disorder. It was earlier regulated under Schedule H.
The ministry noted that the drug has reportedly been misused for its sedative, euphoric, and dissociative effects. Authorities have reported seizures of illegally stocked and unauthorized sale of Pregabalin from parts of the country.
Thus, the move to add it to Schedule H1 aims to:
In a gazette notification, the ministry said Pregabalin can now be sold only after a registered medical practitioner’s prescription.
The revised classification mandates that:
All stakeholders, including manufacturers, distributors, wholesalers, retailers, and pharmacists, are advised to ensure strict compliance with the provisions of the notification.
Also read: India Cracks Down On Injectable Cosmetic Procedures In Beauty Clinics
A 2025 study led by researchers at Columbia University Irving Medical Center linked Pregabalin with a surprisingly large increase in the risk of heart failure among older patients with known heart disease.
The study found that Pregabalin was associated with a 48 per cent higher risk of developing heart failure.
For patients with an existing history of heart disease, the risk jumped to 85 per cent. In absolute terms, the researchers estimated around six additional cases of heart failure per 1,000 people taking Pregabalin each year, compared to those not on the drug.
Like all medicines, Pregabalin carries side effects. Common ones include headaches, nausea, diarrhoea, blurred vision, and memory issues. Rarely, it can trigger a life-threatening allergic reaction called anaphylaxis.
If you take Pregabalin, do not stop it suddenly. Stopping abruptly can cause withdrawal-like symptoms. Instead, book an appointment with your GP or specialist to discuss the risks and benefits in your specific case.
If you have a history of heart disease, a heart condition, or new symptoms such as increased breathlessness, persistent swelling, or faintness, mention them promptly.
Pregabalin helps many people with otherwise disabling nerve pain, but like any tool, it must be used with care and attention to context. For older adults and those with heart disease, a conversation with a clinician could be the difference between control and complication.
Earlier this week, the Central Drugs Standard Control Organisation tightened rules around cosmetic use, amid growing concerns that injectable aesthetic procedures are gaining popularity as “cosmetic” treatments in beauty clinics and wellness centers across the country.
In a new public notice issued this week, the CDSCO stated that cosmetic products that come in injectable form do not fall under the definition of cosmetics under the law. It said that such products are not permitted for use by consumers, professionals, or aesthetic clinics.
© 2024 Bennett, Coleman & Company Limited